AbCellera
cro drug development fails too often mele seme a ted to years of rate ory drug development average antibody forester tech access impact drug developers focus on getting one result is drug candidate to the finish line the a chronic in the technologies to make the process of drug development better | AbCellera
Company
Deck Type
IPO
Sector
Industry
Deck date
December 2020
Slide
5 of 38
Related slides by other companies
Absci
Investor Presentation
October 2023
the drug discovery paradigm is ripe for disruption a | Absci
Absci
Investor Conference
January 2023
what if the next transformative drug was not discovered but created with a click of a button | Absci
Absci
Investor Presentation
October 2023
what if the next transformative drug was not discovered but created with a click of a button | Absci
Memechat
Start Up
February 2021
founders kyle years experience in social media as serial a distribution of entrepreneurs and built pages with million following core team as years data science and tech development arjun years of specific | Memechat
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights